{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:16:10Z","timestamp":1790270170451,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>A global gold standard framework for primary immunodeficiency (PID) care, structured around six principles, was published in 2014. To measure the implementation status of these principles IPOPI developed the PID Life Index in 2020, an interactive tool aggregating national PID data. This development was combined with a revision of the principles to consider advances in the field of health and science as well as political developments since 2014. The revision resulted in the following six principles: PID diagnosis, treatments, universal health coverage, specialised centres, national patient organisations and registries for PIDs. A questionnaire corresponding to these principles was sent out to IPOPI\u2019s national member organisations and to countries in which IPOPI had medical contacts, and data was gathered from 60 countries. The data demonstrates that, regardless of global scientific progress on PIDs with a growing number of diagnostic tools and better treatment options becoming available, the accessibility and affordability of these remains uneven throughout the world. It is not only visible between regions, but also between countries within the same region. One of the most urgent needs is medical education. In countries without immunologists, patients with PID suffer the risk of remaining undiagnosed or misdiagnosed, resulting in health implications or even death. Many countries also lack the infrastructure needed to carry out more advanced diagnostic tests and perform treatments such as hematopoietic stem cell transplantation or gene therapy. The incapacity to secure appropriate diagnosis and treatments affects the PID environment negatively in these countries. Availability and affordability also remain key issues, as diagnosis and treatments require coverage\/reimbursement to ensure that patients with PID can access them in practice, not only in theory. This is still not the case in many countries of the world according to the PID Life Index. Although some countries do perform better than others, to date no country has fully implemented the PID principles of care, confirming the long way ahead to ensure an optimal environment for patients with PID in every country.<\/jats:p>","DOI":"10.3389\/fimmu.2021.780140","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T09:26:44Z","timestamp":1637227604000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index"],"prefix":"10.3389","volume":"12","author":[{"given":"Julia","family":"Nordin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Pr\u00e9vot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Mahlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Chapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez-Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adli","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Pergent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00980-1","article-title":"The Ever-Increasing Array of Novel Inborn Errors of Immunity: An Interim Update by the IUIS Committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00627","article-title":"Primary Immune Deficiencies \u2013 Principles of Care","volume":"5","author":"Chapel","year":"2014","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.625753","article-title":"Primary Immunodeficiencies: A Decade of Progress and a Promising Future","volume":"11","author":"Meyts","year":"2021","journal-title":"Front Immunol"},{"key":"B4","unstructured":"The Selection and Use of Essential In Vitro Diagnostics - TRS 10312021"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global Systematic Review of Primary Immunodeficiency Registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170561","article-title":"Newborn Screening for Severe Combined Immunodeficiency: A Primer for Clinicians","volume":"189","author":"Biggs","year":"2017","journal-title":"CMAJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","article-title":"Primary Immunodeficiency","volume":"14","author":"McCusker","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S60771","article-title":"Improving Current Immunoglobulin Therapy for Patients With Primary Immunodeficiency: Quality of Life and Views on Treatment","volume":"2018","author":"Espa\u00f1ol","year":"2014","journal-title":"Dove Press J: Patient Preference Adherence"},{"key":"B9","volume-title":"World Health Organization Model List of Essential Medicines: 21st List 2019","year":"2019"},{"key":"B10","volume-title":"World Health Organization Model List of Essential Medicines for Children: 7th List 2019","year":"2019"},{"key":"B11","unstructured":"Asia-Pacific Economic CooperationKey APEC Documents 2017"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444700","article-title":"European Consensus Proposal for Immunoglobulin Therapies","volume":"44","author":"Sewell","year":"2014","journal-title":"Eur J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.08.006","article-title":"Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies","volume":"28","author":"Kang","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705273","article-title":"Hematopoietic Stem Cell Transplantation for 30 Patients With Primary Immunodeficiency Diseases: 20 Years Experience of a Single Team","volume":"37","author":"Tsuji","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.018","article-title":"Evolving Gene Therapy in Primary Immunodeficiency","volume":"25","author":"Thrasher","year":"2017","journal-title":"Mol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz170","article-title":"Gene Therapy for Primary Immunodeficiency","volume":"28","author":"Booth","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","article-title":"Thymus Transplantation for Complete DiGeorge Syndrome: European Experience","volume":"140","author":"Davies","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B18","unstructured":"European Vaccination Information PortalVaccination2020"},{"key":"B19","unstructured":"Vaccines and Immunization"},{"key":"B20","unstructured":"WHO Resolution WHA69.11 on Health in the 2030 Agenda for Sustainable Development\u201d2016"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108359","article-title":"Cost and Impact of Early Diagnosis in Primary Immunodeficiency Disease: A Literature Review","volume":"213","author":"Elsink","year":"2020","journal-title":"Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I Treat Common Variable Immune Deficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.36290\/vnl.2019.023","article-title":"Primary Immunodeficiencies in Adults. Prim\u00e1rn\u00ed Imunodeficience U Dosp\u011bl\u00fdch","volume":"65","author":"Litzman","year":"2019","journal-title":"Vnitr Lek"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0404-8","article-title":"Health-Related Quality of Life in Adult Patients With Common Variable Immunodeficiency Disorders and Impact of Treatment","volume":"37","author":"Rider","year":"2017","journal-title":"J Clin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6672.516","article-title":"Primary Antibody Deficiency and Diagnostic Delay","volume":"298","author":"Blore","year":"1989","journal-title":"Br MedJ"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-020-00340-z","article-title":"Current Transition Management of Adolescents and Young Adults With Allergy and Asthma: A European Survey","volume":"10","author":"Khaleva","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"B27","unstructured":"Specialised Centres2021"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60875-2","article-title":"Empowerment of Patients: Lessons From the Rare Diseases Community","volume":"371","author":"Aym\u00e9","year":"2008","journal-title":"Lancet"},{"key":"B29","unstructured":"Member Organisations2021"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000696","article-title":"Global Immunoglobulin Supply: Steaming Towards the Iceberg","volume":"20","author":"Prevot","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01439","article-title":"Changing the Lives of People With Primary Immunodeficiencies (PI) With Early Testing and Diagnosis","volume":"9","author":"Condino-Neto","year":"2018","journal-title":"Front Immunol"},{"key":"B32","unstructured":"United Nations Convention on the Rights of Persons With Disabilities. Article 1 \u2013 Purpose2006"},{"key":"B33","unstructured":"Russia \u2013 NMO OPPID Part of \u201cImmunity 2021: Doctor-Patient-Society\u201d International Meeting2021"},{"key":"B34","unstructured":"France \u2013 10 Clinical Warning Signs of PID Now in Video2021"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3282f2162c","article-title":"Primary Immunodeficiency Registries","volume":"7","author":"Knerr","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13223-021-00551-4","article-title":"Clinical and Demographic Pattern of Chronic Granulomatous Disease (CGD) From a Multicenter Perspective: Malaysia\u2019s Experience Over 26 Years","volume":"17","author":"Noh","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02548","article-title":"Inoculating a New Generation: Immunology in Medical Education","volume":"10","author":"Haidaris","year":"2019","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/jt1.jaci.2016.09.023","article-title":"Update on the Use of Immunoglobulin in Human Disease: A Review of Evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.780140\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T09:26:52Z","timestamp":1637227612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.780140\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2021.780140"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.780140","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"article-number":"780140"}}